18
Feb
2014

VIDEO: Coca-Cola Co. Revenue Misses Expectations

Actavis agreed to buy rival drug maker Forest Labs for $25 billion. Plus, key stocks to watch include Coca-Cola and Tesla. MarketWatch’s Victor Reklaitis joins the News Hub. Photo: The Coca-Cola Company.

[grabpress_video guid=4f6d52ba1a85553f1a66e0cfe052da7616a71183 embed_id=2071793]

Thanks for checking us out. Please take a look at the rest of our videos and articles.

To stay in the loop, bookmark our homepage.

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *